Viewing Study NCT04827069


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-01-01 @ 2:41 AM
Study NCT ID: NCT04827069
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2021-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)
Sponsor: Sunshine Lake Pharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module